Estimation of visfatin in serum and tissue of psoriasis patients / Salwa Ismail Ahmed Mahmoud ; Supervised Omar Azzam , Nesrin Samir Abdelfattah , Olfat Gamil Shaker
Material type:
- قياس مستوي الفسفاتين في الانسجة و مصل الدم فى مرضي الصدفية [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.10.M.Sc.2015.Sa.E (Browse shelf(Opens below)) | Not for loan | 01010110068165000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.10.M.Sc.2015.Sa.E (Browse shelf(Opens below)) | 68165.CD | Not for loan | 01020110068165000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Dermatology and Venerology
Background: Psoriasis is a common chronic inflammatory skin condition that varies in severity; it affects 2{u2013}3% of the population. Visfatin a 52-kDa protein has been recently identified as an adipocytokine secreted primarily by visceral adipose tissue and various cells such as neutrophils, monocytes, macrophages, epithelial, endothelial cells and also present in the circulation in various inflammatory conditions. It is related to insulin resistance, obesity, atherosclerotic diseases and type II diabetes. Visfatin is assumed to be closely associated with the metabolic syndrome in addition to its role in inflammatory diseases, role in renal injury and in apoptosis. Objectives: The aim of the present study is to estimate visfatin levels in serum and tissue (lesional and non-lesional) of psoriatic patients and to correlate these levels with markers of the metabolic syndrome and disease severity
Issued also as CD
There are no comments on this title.